SEARCH RESULTS FOR:

James Greenwood

PRESIDENT & CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
The Biotechnology Innovation Organization (BIO) represents biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.

Enrique Flaiban

GENERAL MANAGER, PETROCUYO
Petrocuyo is an Argentinian company that resulted from the merger between Petroquímica Cuyo and Petroken.

Doug Giordano

SENIOR VP, BUSINESS DEVELOPMENT, PFIZER
A look at the latest trends in business development from a global pharma powerhouse.

Scott Baker

CEO, TORNADO SPECTRAL SYSTEMS
United States Biopharmaceuticals 2019 Pre-Release Edition
Tornado Spectral Systems is a Toronto-based startup that designs, manufactures and sells dispersive optical spectrometers and systems for Raman spectroscopy.

Peru’s Mining Industry Grows on Autopilot

Peru Mining 2019 Pre-Release Edition 1
The country’s mining sector isolates itself from the political noise to continue promoting its mineral production

Innovative Mining Solutions

Québec Mining 2019 Pre-Release Edition
Québec’s mining service industry is at the forefront of the evolution towards the modern mine

Brian Maher

PRESIDENT AND CEO, PPX MINING
Peru Mining 2019 Pre-Release Edition 1
PPX Mining is a Canadian-based exploration and development company with assets in northern Peru.

Duane Nelson

CEO AND DIRECTOR, ENVIROLEACH
EnviroLeach offers gold miners an alternative for cyanide and explores recycling techniques

Denver Dreyer

CEO, WORLEYPARSONS RSA
THE OFFICIAL MINING IN AFRICA COUNTRY INVESTMENT GUIDE (MACIG) 2019
WorleyParsons is an engineering company that provides project delivery and consulting services to the resources and energy sectors, and complex process industries.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.

PARTNER EVENTS